Literature DB >> 22556270

Low-dose gamma-irradiation inhibits IL-6 secretion from human lung fibroblasts that promotes bronchial epithelial cell transformation by cigarette-smoke carcinogen.

Wenshu Chen1, Xiuling Xu, Lang Bai, Mabel T Padilla, Katherine M Gott, Shuguang Leng, Carmen S Tellez, Julie A Wilder, Steven A Belinsky, Bobby R Scott, Yong Lin.   

Abstract

Despite decades of research in defining the health effects of low-dose (<100 mGy) ionizing photon radiation (LDR), the relationship between LDR and human cancer risk remains elusive. Because chemical carcinogens modify the tumor microenvironment, which is critical for cancer development, we investigated the role and mechanism of LDR in modulating the response of stromal cells to chemical carcinogen-induced lung cancer development. Secretion of proinflammatory cytokines such as interleukin-6 (IL-6), CXCL1 and CXCL5 from human lung fibroblasts was induced by cigarette-smoke carcinogen benzo[a]pyrene diol epoxide (BPDE), which was inhibited by a single dose of LDR. The activation of NF-κB, which is important for BPDE-induced IL-6 secretion, was also effectively suppressed by LDR. In addition, conditioned media from BPDE-treated fibroblasts activated STAT3 in the immortalized normal human bronchial epithelial cell line Beas-2B, which was blocked with an IL-6 neutralizing antibody. Conditioned medium from LDR-primed and BPDE-treated fibroblast showed diminished capacity in activating STAT3. Furthermore, IL-6 enhanced BPDE-induced Beas-2B cell transformation in vitro. These results suggest that LDR inhibits cigarette smoke-induced lung carcinogenesis by suppressing secretion of cytokines such as IL-6 from fibroblasts in lung tumor-prone microenvironment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556270     DOI: 10.1093/carcin/bgs159

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

Review 1.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop.

Authors:  Xiuling Xu; Wenshu Chen; Shuguang Leng; Mabel T Padilla; Bryanna Saxton; Julie Hutt; Mathewos Tessema; Kosuke Kato; Kwang Chul Kim; Steven A Belinsky; Yong Lin
Journal:  Carcinogenesis       Date:  2017-06-01       Impact factor: 4.944

3.  The nucleotide excision repair protein XPC is essential for bulky DNA adducts to promote interleukin-6 expression via the activation of p38-SAPK.

Authors:  I Schreck; N Grico; I Hansjosten; C Marquardt; S Bormann; A Seidel; D L Kvietkova; D Pieniazek; D Segerbäck; S Diabaté; G T J van der Horst; B Oesch-Bartlomowicz; F Oesch; C Weiss
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

4.  Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy.

Authors:  Bobby R Scott
Journal:  J Cell Commun Signal       Date:  2014-10-17       Impact factor: 5.782

5.  MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.

Authors:  Xiuling Xu; Mabel T Padilla; Bilan Li; Alexandria Wells; Kosuke Kato; Carmen Tellez; Steven A Belinsky; Kwang Chul Kim; Yong Lin
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

6.  Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation.

Authors:  Hong Qiong Yan; Xiao Bo Huang; Shi Zhong Ke; Yi Na Jiang; Yue Hua Zhang; Yi Nan Wang; Juan Li; Feng Guang Gao
Journal:  Cancer Sci       Date:  2014-09-08       Impact factor: 6.716

7.  Radon Exposure, IL-6 Promoter Variants, and Lung Squamous Cell Carcinoma in Former Uranium Miners.

Authors:  Shuguang Leng; Cynthia L Thomas; Amanda M Snider; Maria A Picchi; Wenshu Chen; Derall G Willis; Teara G Carr; Jacek Krzeminski; Dhimant Desai; Amin Shantu; Yong Lin; Marty R Jacobson; Steven A Belinsky
Journal:  Environ Health Perspect       Date:  2015-09-15       Impact factor: 9.031

8.  Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences.

Authors:  Taisuke Akamatsu; Yosifumi Arai; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Makiko Sakao; Kiyoshi Shibata; Takafumi Suda; Kingo Chida; Toshihide Iwashita
Journal:  Fibrogenesis Tissue Repair       Date:  2013-08-08

9.  Curcumin Nanoformulation for Cervical Cancer Treatment.

Authors:  Mohd S Zaman; Neeraj Chauhan; Murali M Yallapu; Rishi K Gara; Diane M Maher; Sonam Kumari; Mohammed Sikander; Sheema Khan; Nadeem Zafar; Meena Jaggi; Subhash C Chauhan
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

10.  The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution.

Authors:  Gui-Zhen Wang; Xin Cheng; Bo Zhou; Zhe-Sheng Wen; Yun-Chao Huang; Hao-Bin Chen; Gao-Feng Li; Zhi-Liang Huang; Yong-Chun Zhou; Lin Feng; Ming-Ming Wei; Li-Wei Qu; Yi Cao; Guang-Biao Zhou
Journal:  Elife       Date:  2015-11-13       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.